Estrapronicate
Iupac name[(8R,9S,13S,14S,17S)-13-Methyl-3-propanoyloxy-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] pyridine-3-carboxylate
Width250px
Routes of administrationIntramuscular injection
ClassEstrogen; Estrogen ester
Cas number4140-20-9
UniiBC621AC03L
Pubchem66433
Chemspiderid59806
SynonymsEstradiol propionicotinate; Estradiol propionate nicotinate; Estradiol nicotinate propionate; Estradiol 17β-nicotinate 3-propionate
C27
H31
N1
O4
SmilesCCC(=O)OC1=CC2=C(C=C1)C3CCC4(C(C3CC2)CCC4OC(=O)C5=CN=CC=C5)C
Stdinchi1S/C27H31NO4/c1-3-25(29)31-19-7-9-20-17(15-19)6-8-22-21(20)12-13-27(2)23(22)10-11-24(27)32-26(30)18-5-4-14-28-16-18/h4-5,7,9,14-16,21-24H,3,6,8,10-13H2,1-2H3/t21-,22-,23+,24+,27+/m1/s1
StdinchikeyFXMSQUVSUXBBAB-TXDQRGGKSA-N

Estrapronicate (INN), also known as estradiol nicotinate propionate is an estrogen medication and estrogen ester which was never marketed.[1] It was studied as a component of the experimental tristeroid combination drug Trophobolene, which contained nandrolone decanoate, estrapronicate, and hydroxyprogesterone heptanoate.[2][3]

See also

References

  1. ^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 898–. ISBN 978-1-4757-2085-3.
  2. ^ Excerpta medica. Section 8, Neurology and neurosurgery. 1981. p. 10.
  3. ^ Testosterone Congeners—Advances in Research and Application: 2013 Edition: ScholarlyBrief. ScholarlyEditions. 21 June 2013. pp. 137–. ISBN 978-1-4816-9288-5.